## Supplementary Figures

### IL-2 variants' affinities for IL-2R subunits.

|    Ligand      	|    IL-2Rα Affinity ($K_D$)	|    IL-2Rβ/γ~c~ Affinity ($K_D$)         	| 
|--------------------------	|--------------	|--------------------------	|
|    WT IL-2      	|    10.0   	|    0.133	|
|    WT N-term        	|    0.19   	|    5.296	|
|    WT C-term        	|    0.54   	|    3.043	|
|    V91K C-term       	|    0.69   	|    7.5586	|
|    R38Q N-term       	|    0.71   	|    3.9949	|
|    F42Q N-Term        	|    9.48   	|    2.815	|
|    N88D C-term        	|    1.01   	|    24.0166	|
|    H16N N-term        	|    0.43   	|    22.35	|
|    R38Q/H16N       	|    0.71   	|    22.35	|

![**Receptor quantification and gating of PBMC-derived immune cell types.** A&B) Gating for fixed Thelper and Treg cells during pSTAT5 quantification. C&D) Fixed CD8+ T cell and NK cell gating. E&F) Gating for live Thelper and Treg cells during receptor quantification. G) Live cell NK cell gating. H) Live cell CD8+ cell gating. I) Receptor quantification for each cell type. J) IL2-R versus IL2-R correlation for Treg cells. K) IL2-R versus IL2-R correlation for Treg cells.](./output/figureS1.svg){#fig:S1 tag="S1"}

![**Signaling heterogeneity is explained by multivalent binding model.** A) .](./output/figureS2.svg){#fig:S2 tag="S2"}

![**Complete dose-response curves for all cell types and ligands.** Experimental pSTAT5 measurements are represented by dots. Predicted pSTAT5 responses are shown represented by lines.](./output/figureS3.svg){#fig:S3 tag="S3"}
